Amedeo Smart

Free Medical Literature Service

 

Amedeo

Head and Neck Cancer
  Free Subscription

Articles published in
Br J Cancer
    June 2025
  1. VAN HEUSDEN HC, van Beers MA, Schaeffers AWMA, Swartz E, et al
    The predictive and prognostic role of radiologically defined sarcopenia in head and neck cancer: a systematic review and multi-level meta-analysis.
    Br J Cancer. 2025 Jun 2. doi: 10.1038/s41416-025-03049.
    >> Share

  2. TRAN TV, O'Brien KM, Troisi R, Sandler DP, et al
    In-utero and newborn factors and thyroid cancer incidence in adult women in the Sister Study cohort.
    Br J Cancer. 2025;132:1056-1063.
    >> Share

  3. DE OLIVEIRA THA, Anderson LA, Craig SG, Coleman HG, et al
    Infectious agents and progression from Barrett's oesophagus to oesophageal adenocarcinoma: a nested case-control study.
    Br J Cancer. 2025;132:1050-1055.
    >> Share

    May 2025
  4. CUI K, Hu S, Zha Y, Ding K, et al
    CD49a(+) NK cells promote esophageal cancer development by inducing MDCSs infiltration via GM-CSF.
    Br J Cancer. 2025 May 28. doi: 10.1038/s41416-025-03065.
    >> Share

  5. PAPANIKOLAOU C, Economopoulou P, Spathis A, Kotsantis I, et al
    Association of DNA damage response signals and oxidative stress status with nivolumab efficacy in patients with Head and Neck Squamous Cell Carcinoma.
    Br J Cancer. 2025 May 23. doi: 10.1038/s41416-025-03032.
    >> Share

  6. FEI-ZHANG DJ, Cuenca CM, Haskins AD, Stein AP, et al
    Assessments of social vulnerability on laryngeal cancer treatment & prognosis in the US.
    Br J Cancer. 2025 May 15. doi: 10.1038/s41416-025-03056.
    >> Share

  7. LAN K, Li S, Jia G, Li S, et al
    Biomarkers of response to camrelizumab combined with apatinib: an analysis from a phase II trial in recurrent/metastatic nasopharyngeal carcinoma.
    Br J Cancer. 2025 May 12. doi: 10.1038/s41416-025-03044.
    >> Share

  8. CHENG H, Chen J, Li Y, Li Y, et al
    Determining the optimal duration of oral adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
    Br J Cancer. 2025 May 6. doi: 10.1038/s41416-025-03033.
    >> Share

  9. HUBER D, Kors TA, Schutt L, Hofmann L, et al
    The role of plasma-derived small extracellular vesicles in pre-metastatic niche formation through modulation of macrophages in head and neck squamous cell carcinoma.
    Br J Cancer. 2025 May 5. doi: 10.1038/s41416-025-03001.
    >> Share

    April 2025
  10. INOUE-CHOI M, Ramirez Y, O'Connell C, Berrington de Gonzalez A, et al
    Hot beverage intake and oesophageal cancer in the UK Biobank: prospective cohort study.
    Br J Cancer. 2025;132:652-659.
    >> Share

  11. HUANG G, Chen S, Han B, Zhang G, et al
    Apolipoprotein D is crucial for promoting perineural invasion in salivary adenoid cystic carcinoma.
    Br J Cancer. 2025;132:599-610.
    >> Share

    March 2025
  12. LU X, Lin W, Zheng J, Huang W, et al
    Sodium nitrite orchestrates macrophage mimicry of tongue squamous carcinoma cells to drive lymphatic metastasis.
    Br J Cancer. 2025;132:340-353.
    >> Share

    February 2025
  13. SHEPHARD AJ, Mahmood H, Raza SEA, Khurram SA, et al
    A novel AI-based score for assessing the prognostic value of intra-epithelial lymphocytes in oral epithelial dysplasia.
    Br J Cancer. 2025;132:168-179.
    >> Share

  14. STOGBAUER F, Wirth M, Lauterbach M, Wollenberg B, et al
    Tumor budding and lymphovascular invasion as prognostic factors in p16-positive oropharyngeal squamous cell carcinomas.
    Br J Cancer. 2025;132:212-221.
    >> Share

  15. BARGHOUT SH, Meti N, Chotai S, Kim CJH, et al
    Adaptive Universal Principles for Real-world Observational Studies (AUPROS): an approach to designing real-world observational studies for clinical, epidemiologic, and precision oncology research.
    Br J Cancer. 2025;132:139-153.
    >> Share

    December 2024
  16. LIN J, Orestes MI, Shriver CD, Zhu K, et al
    Post-diagnosis statin use and survival among head and neck cancer patients: a cohort study in a universal health care system.
    Br J Cancer. 2024 Dec 7. doi: 10.1038/s41416-024-02925.
    >> Share

    November 2024
  17. EKSTEDT S, Piersiala K, Kolev A, Farrajota Neves da Silva P, et al
    Phenotypical differences of neutrophils patrolling tumour-draining lymph nodes in head and neck cancer.
    Br J Cancer. 2024 Nov 14. doi: 10.1038/s41416-024-02891.
    >> Share

    October 2024
  18. HOLZMANN KLK, Wolf JL, Stangl S, Lennartz P, et al
    Improved ex vivo fluorescence imaging of human head and neck cancer using the peptide tracer TPP-IRDye800 targeting membrane-bound Hsp70 on tumor cells.
    Br J Cancer. 2024 Oct 15. doi: 10.1038/s41416-024-02872.
    >> Share

  19. ZHOU J, Zhao G, Wang S, Li N, et al
    Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review of the last decade.
    Br J Cancer. 2024;131:1021-1031.
    >> Share

  20. CHEN YY, Wang PP, Hu Y, Yuan Y, et al
    Clinical efficacy and immune response of neoadjuvant camrelizumab plus chemotherapy in resectable locally advanced oesophageal squamous cell carcinoma: a phase 2 trial.
    Br J Cancer. 2024;131:1126-1136.
    >> Share

    September 2024
  21. WANG R, Liu S, Chen B, Li Q, et al
    Prognostic significance of PET/CT and its association with immuno-genomic profiling in oesophageal squamous cell carcinoma treated with immunotherapy plus chemoradiotherapy: results from a phase II study.
    Br J Cancer. 2024;131:709-717.
    >> Share

    July 2024
  22. HARA Y, Baba Y, Oda E, Harada K, et al
    Presence of Fusobacterium nucleatum in relation to patient survival and an acidic environment in oesophagogastric junction and gastric cancers.
    Br J Cancer. 2024 Jul 12. doi: 10.1038/s41416-024-02753.
    >> Share

  23. LI T, Sun G, Ye H, Song C, et al
    ESCCPred: a machine learning model for diagnostic prediction of early esophageal squamous cell carcinoma using autoantibody profiles.
    Br J Cancer. 2024 Jul 2. doi: 10.1038/s41416-024-02781.
    >> Share

    May 2024
  24. ZHANG D, Jiang D, Jiang L, Ma J, et al
    HLA-A(+) tertiary lymphoid structures with reactivated tumor infiltrating lymphocytes are associated with a positive immunotherapy response in esophageal squamous cell carcinoma.
    Br J Cancer. 2024 May 18. doi: 10.1038/s41416-024-02712.
    >> Share

  25. OLIVA M, Heirali A, Watson G, Rooney AM, et al
    Prospective manipulation of the gut microbiome with microbial ecosystem therapeutic 4 (MET4) in HPV-related locoregionally-advanced oropharyngeal cancer squamous cell carcinoma (LA-OPSCC) undergoing primary chemoradiation: ROMA2 study.
    Br J Cancer. 2024 May 7. doi: 10.1038/s41416-024-02701.
    >> Share

  26. WANG C, Li Y, Wang L, Han Y, et al
    SPP1 represents a therapeutic target that promotes the progression of oesophageal squamous cell carcinoma by driving M2 macrophage infiltration.
    Br J Cancer. 2024;130:1770-1782.
    >> Share

  27. WANG Z, Tang S, Cai L, Wang Q, et al
    DRP1 inhibition-mediated mitochondrial elongation abolishes cancer stemness, enhances glutaminolysis, and drives ferroptosis in oral squamous cell carcinoma.
    Br J Cancer. 2024;130:1744-1757.
    >> Share

  28. SIJBEN J, Huibertse LJ, Rainey L, Broeders MJM, et al
    Oesophageal cancer awareness and anticipated time to help-seeking: results from a population-based survey.
    Br J Cancer. 2024;130:1795-1802.
    >> Share

    April 2024
  29. MAKOWSKA A, Kontny U, Weiskirchen R
    HeLa cells cross-contaminated nasopharyngeal carcinoma cell lines: Still a common problem.
    Br J Cancer. 2024 Apr 25. doi: 10.1038/s41416-024-02675.
    >> Share

  30. TABATABAEIAN H, Bai Y, Huang R, Chaurasia A, et al
    Navigating therapeutic strategies: HPV classification in head and neck cancer.
    Br J Cancer. 2024 Apr 20. doi: 10.1038/s41416-024-02655.
    >> Share

    March 2024
  31. HIRAI R, Kinugasa H, Yamamoto S, Ako S, et al
    Methylation analysis of DCC gene in saliva samples is an efficient method for non-invasive detection of superficial hypopharyngeal cancer.
    Br J Cancer. 2024 Mar 27. doi: 10.1038/s41416-024-02654.
    >> Share

  32. XU J, Chen D, Wu W, Ji X, et al
    A metabolic map and artificial intelligence-aided identification of nasopharyngeal carcinoma via a single-cell Raman platform.
    Br J Cancer. 2024 Mar 7. doi: 10.1038/s41416-024-02637.
    >> Share

  33. SHANG Q, Jiang Y, Wan Z, Peng J, et al
    The clinical implication and translational research of OSCC differentiation.
    Br J Cancer. 2024;130:660-670.
    >> Share

  34. CHENG Z, Johar A, Nilsson M, Schandl A, et al
    Cancer-related fatigue trajectories up to 5 years after curative treatment for oesophageal cancer.
    Br J Cancer. 2024;130:628-637.
    >> Share

    February 2024
  35. CECCHINI M, Cleary JM, Shyr Y, Chao J, et al
    NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma.
    Br J Cancer. 2024;130:476-482.
    >> Share

  36. JAVED SR, Lord S, El Badri S, Harman R, et al
    CHARIOT: a phase I study of berzosertib with chemoradiotherapy in oesophageal and other solid cancers using time to event continual reassessment method.
    Br J Cancer. 2024;130:467-475.
    >> Share

    January 2024
  37. LIN W, Chen X, Huang Z, Ding Q, et al
    Identification of novel molecular subtypes to improve the classification framework of nasopharyngeal carcinoma.
    Br J Cancer. 2024 Jan 27. doi: 10.1038/s41416-024-02579.
    >> Share

  38. LI G, Wang H, Zhong J, Bai Y, et al
    Circulating small extracellular vesicle-based miRNA classifier for follicular thyroid carcinoma: a diagnostic study.
    Br J Cancer. 2024 Jan 18. doi: 10.1038/s41416-024-02575.
    >> Share

  39. CHEN Y, Feng Y, Lin Y, Zhou X, et al
    GSTM3 enhances radiosensitivity of nasopharyngeal carcinoma by promoting radiation-induced ferroptosis through USP14/FASN axis and GPX4.
    Br J Cancer. 2024 Jan 16. doi: 10.1038/s41416-024-02574.
    >> Share

  40. STOGBAUER F, Beck S, Ourailidis I, Hess J, et al
    Correction: Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer.
    Br J Cancer. 2024 Jan 8. doi: 10.1038/s41416-023-02521.
    >> Share

  41. HUANG Q, Liu Z, Yu Y, Rong Z, et al
    Prediction of response to neoadjuvant chemo-immunotherapy in patients with esophageal squamous cell carcinoma by a rapid breath test.
    Br J Cancer. 2024 Jan 4. doi: 10.1038/s41416-023-02547.
    >> Share

  42. CLEMENTS HA, Underwood TJ, Petty RD
    Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma.
    Br J Cancer. 2024;130:9-18.
    >> Share

    December 2023
  43. ALMANGUSH A, Makitie AA, Leivo I
    Tumour budding in head and neck cancer: what have we learnt and the next steps towards clinical implementation.
    Br J Cancer. 2023 Dec 14. doi: 10.1038/s41416-023-02531.
    >> Share

  44. SARODE G, Sarode SC
    Comment on "Development and validation of a multivariable model for prediction of malignant transformation and recurrence of oral epithelial dysplasia".
    Br J Cancer. 2023;129:1875-1876.
    >> Share

    November 2023
  45. MAHMOOD H, Shephard A, Hankinson P, Bradburn M, et al
    Development and validation of a multivariable model for prediction of malignant transformation and recurrence of oral epithelial dysplasia.
    Br J Cancer. 2023;129:1599-1607.
    >> Share

  46. MENG X, Zheng A, Wang J, Wu X, et al
    Nimotuzumab plus concurrent chemo-radiotherapy in unresectable locally advanced oesophageal squamous cell carcinoma (ESCC): interim analysis from a Phase 3 clinical trial.
    Br J Cancer. 2023;129:1787-1792.
    >> Share

  47. TOWLE R, Dickman CTD, MacLellan SA, Chen J, et al
    Identification of a serum-based microRNA signature that detects recurrent oral squamous cell carcinoma before it is clinically evident.
    Br J Cancer. 2023;129:1810-1817.
    >> Share

    October 2023
  48. LIU JY, Yu ZL, Fu QY, Zhang LZ, et al
    Immunosuppressive effect of small extracellular vesicle PD-L1 is restricted by co-expression of CD80.
    Br J Cancer. 2023;129:925-934.
    >> Share

    September 2023
  49. PAYNE K, Brooks J, Batis N, Khan N, et al
    Feasibility of mass cytometry proteomic characterisation of circulating tumour cells in head and neck squamous cell carcinoma for deep phenotyping.
    Br J Cancer. 2023 Sep 21. doi: 10.1038/s41416-023-02428.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016